2024 - Passed
Tennessee H.B.37
  • Aligns group health insurance plans providing coverage for state employees with Medicaid non-opioid parity policy, ensuring reimbursement of all FDA-approved non-opioid drugs.
2026 - Introduced
Virginia H.B. 516
  • Prohibits commercial health insurers from imposing limitations or utilization controls on coverage of a covered FDA-approved non-opioid drug that are more restrictive or less favorable to the enrollee relative to the coverage of an opioid drug for the treatment or management of pain.
2026 - Introduced
Washington S.B. 5916
  • Prohibits public and private health plans from disadvantaging non-opioid pain medications that are more restrictive or less favorable to the enrollee relative to the coverage of an opioid drug for the treatment or management of pain.
  • Requires the state to publish an educational pamphlet on non-opioid pain treatment alternatives.